Prostatis Group’s Vanguard Small-Cap ETF VB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-1,045
Closed -$228K 152
2024
Q2
$228K Buy
1,045
+19
+2% +$4.17K 0.08% 135
2024
Q1
$235K Buy
+1,026
New +$221K 0.09% 126
2023
Q1
Sell
-21,727
Closed -$3.99M 112
2022
Q4
$3.99M Buy
+21,727
New +$4.03M 2.43% 12
2022
Q2
Sell
-18,312
Closed -$3.89M 86
2022
Q1
$3.89M Buy
+18,312
New +$3.85M 3.12% 6
2021
Q4
Sell
-7,925
Closed -$1.73M 98
2021
Q3
$1.73M Buy
7,925
+745
+10% +$166K 1.04% 30
2021
Q2
$1.62M Sell
7,180
-492
-6% -$109K 1.1% 27
2021
Q1
$1.64M Sell
7,672
-10,966
-59% -$2.31M 1.29% 20
2020
Q4
$3.63M Buy
+18,638
New +$3.29M 3.04% 9

Other funds holding VB

Prostatis Group's VB Position: Q3 2024 in Review

Prostatis Group sold out of Vanguard Small-Cap ETF (VB) in Q3 2024, closing a stake of 1,045 shares — an estimated $228K sold.

Prostatis Group first reported a position in VB in Q4 2020 and held it in 8 quarters. The position peaked at $3.99M in Q4 2022. 1,972 funds tracked by Wall St. Rank hold VB as of Q3 2024.

  • Prostatis Group reported no remaining Vanguard Small-Cap ETF position as of Q3 2024 after selling out during the quarter.
  • Prostatis Group sold 1,045 Vanguard Small-Cap ETF shares in Q3 2024, an estimated $228K.
  • Prostatis Group first reported a position in Vanguard Small-Cap ETF in Q4 2020 and held it in 8 quarters.
  • Prostatis Group's Vanguard Small-Cap ETF position peaked at $3.99M in Q4 2022.
  • 1,972 funds tracked by Wall St. Rank held Vanguard Small-Cap ETF as of Q3 2024.

Based on Prostatis Group's 13F filing for Q3 2024, filed 21 Mar 2025.